(BA) The Boeing Company BCG Matrix Research |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
(BA) The Boeing Company Bundle
This The Boeing Company BCG Matrix helps you see how Boeing’s products or business units may fall across Stars, Cash Cows, Question Marks, and Dogs for strategy and capital allocation. The page already shows a real preview of the analysis, so you can review the actual format and content before buying. Purchase the full version to get the complete ready-to-use report instantly.
Stars
737 MAX is Boeing’s largest commercial program, with a backlog above 4,000 jets, so it remains the core narrowbody asset in the portfolio. Single-aisle demand is still the biggest market in aviation, driven by fleet replacement and traffic growth. If Boeing keeps output steady near 38 aircraft a month, this backlog can convert into cash faster.
The 787 Dreamliner is Boeing Company’s flagship long-haul twin-aisle jet, with 1,100+ delivered, and it anchors premium international travel where fuel burn and range matter most. It stays in a strong BCG "Star" slot because widebody demand is firm and the model holds a large share of Boeing Company’s twin-aisle portfolio. Airlines keep buying it for lower operating costs on long routes, which supports growth and cash flow.
Boeing's commercial aftermarket is a Star: its 2024 Commercial Services revenue was $22.9B, led by maintenance, parts, and support tied to a huge installed fleet. As flying hours keep recovering and older jets need more checks, demand stays sticky. Boeing also has strong pricing power because it owns the OEM data, parts, and certification path.
F-15EX modernization, 104-aircraft USAF buy
F-15EX is a clear Star in Boeing Company’s BCG mix: the U.S. Air Force has locked in a 104-aircraft buy, and the FY2025 budget still backs the line with 18 more jets. This is not a commodity sale; it sits inside a defense refresh cycle with long-cycle demand and high entry barriers.
Boeing Company holds the prime role, so the program supports margin, factory load, and supplier work. The main signal is simple: committed demand, proven platform, and a named U.S. customer.
- 104-aircraft USAF commitment
- FY2025: 18 more jets funded
- Defense-cycle demand, not commodity demand
- Boeing Company is the prime contractor
Missile defense and space systems, multi-year U.S. funding
Boeing remains tied to long-cycle missile defense and space work, where U.S. defense spending is still near $850B a year. These programs support steady demand from command-and-control, missile warning, and national security space needs, even if unit volumes are low. That makes this a strategic Star, not a scale play.
- Long contracts support visible cash flow.
- Missile defense and space stay mission-critical.
- Low volume, high strategic value.
Stars in Boeing Company’s BCG mix are led by 737 MAX, 787 Dreamliner, and defense franchises like F-15EX. The 737 MAX backlog tops 4,000 jets, the 787 has 1,100+ deliveries, and Boeing Commercial Services posted $22.9B in 2024 revenue, with 2025 funding still supporting F-15EX output. These units combine strong demand, scale, and cash conversion.
| Star | Key data |
|---|---|
| 737 MAX | 4,000+ backlog |
| 787 | 1,100+ delivered |
| Commercial Services | $22.9B revenue |
| F-15EX | 104 ordered; 18 funded in FY2025 |
What is included in the product
Detailed Word Document
Boeing BCG Matrix: assesses aircraft, defense, and services units to guide invest, hold, or divest decisions.
Editable Excel File
One-page Boeing BCG Matrix that quickly spots cash cows, stars, and drag points for faster decisions
Reference Sources
Lists trusted Boeing sources to validate key claims, strengthen credibility, and speed better decisions.
Cash Cows
Boeing's 737 NG installed base is a classic Cash Cow: with a 10,000+ jet 737 family fleet in service, the older aircraft still need parts, repairs, and tech support. That mature aftermarket business grows slowly, but it throws off steady cash because operators keep flying these jets for years. Boeing can keep milking this base through maintenance, spares, and service contracts, even as new aircraft sales move in cycles.
The 767 is a mature workhorse, with more than 1,200 built and a large installed base in cargo and defense. The KC-46A keeps the line alive: Boeing had delivered 76 tankers to the U.S. Air Force by late 2025, while freighter demand still supports production. That makes the 767 line a classic low-growth, high-utilization cash cow for The Boeing Company.
The Boeing Company’s AH-64 Apache sustainment is a classic cash cow: more than 2,000 helicopters are in service worldwide, and each fleet needs upgrades, spares, depot work, and software support. The platform is mature and backed by long defense budgets, so revenue keeps coming even with limited unit growth. That installed base gives The Boeing Company steady aftermarket cash flow, especially as operators extend service life and modernize AH-64E fleets.
CH-47 Chinook sustainment, 1,200+ helicopters
The CH-47 Chinook is a long-lived heavy-lift platform with more than 1,200 helicopters delivered and operators in over 20 countries. Boeing’s value now comes mainly from upgrades, depot work, parts, and sustainment, not new-unit growth. That makes it a classic cash cow with recurring service revenue.
- 1,200+ delivered worldwide
- 20+ operators across defense markets
- Revenue now skews to sustainment
- Long service life supports cash flow
Boeing Capital, lease and financing portfolio
Boeing Capital is a small cash cow inside The Boeing Company, turning aircraft leasing and financing into steady fee and interest income. In 2025, it remained far smaller than Boeing's core Commercial Airplanes and Defense units, so it needs little new product spend to keep generating cash.
- Small portfolio, steady cash generation
- Mature, low-growth financing market
- Limited capex needs versus core units
Boeing’s cash cows are mature fleets and services: 737 NG aftermarket, 767, Apache, Chinook, and Boeing Capital. They grow slowly, but installed bases keep parts, upgrades, and support cash flowing.
The 767 fleet topped 1,200 built, and Boeing had delivered 76 KC-46A tankers by late 2025. Apache and Chinook sustainment also stay steady, with over 2,000 Apaches in service and 1,200+ Chinooks delivered.
| Asset | 2025-26 fact |
|---|---|
| 737 NG | 10,000+ fleet |
| Boeing Capital | Small, steady income |
Full Version Awaits
The Boeing Company Reference Sources
This preview shows the exact Boeing Company BCG Matrix document you’ll receive after purchase. No sample pages or hidden changes—just the complete, ready-to-use report. It’s formatted for quick review, sharing, and strategic analysis. What you see here is the final file you’ll download.
Dogs
The 747-8 is a classic Dog in Boeing’s BCG Matrix: low growth, low share, and no clear comeback. Boeing ended 747 production in 2023 after 55 years, and the type never gained wide commercial traction, with only 155 747-8s built across passenger and freighter versions. The market has moved to more fuel-efficient twin-engine jets like the 777 and 787, so demand is now limited to niche cargo and VIP use.
The 757 is a Dog: Boeing ended commercial production in 2004 after 1,050 deliveries, so there is no active build line to drive new revenue. Replacement demand has already moved to newer narrowbody jets like the 737 MAX and Airbus A321neo, which offer lower seat-mile costs and better fuel burn. With no growth leverage left, the 757 mainly supports aftermarket parts and freighter conversions, not future expansion.
The 737-700 passenger model is a mature, retired asset: Boeing ended 737NG production in 2019, and new demand has shifted to the 737 MAX family. With only a shrinking operator base left, it sits in a narrow niche and has little pricing power or growth runway. In BCG terms, it is a weak Dog that ties up support costs without adding much to 2025/2026 fleet value.
CST-100 Starliner, low flight cadence
CST-100 Starliner fits Dogs: Boeing has spent years and billions on a program with slow cadence and only one crewed test flight completed, while NASA’s Commercial Crew market has just two active suppliers. That makes the addressable market small and heavily contested, and Boeing’s returns have lagged the capital tied up in the program.
- Low flight cadence; limited revenue volume
- Small market; only NASA crew demand
- Weak return on invested capital
Space Launch System core stage, low cadence program
Boeing Company’s Space Launch System core stage is a Dogs asset: NASA-led, with only a few flights planned across years, so it doesn’t scale like a commercial launcher. Artemis I flew in 2022, but the program still depends on government funding and one-off missions, tying up engineering effort without broad share growth.
- Low launch cadence
- No commercial scale
- Government-funded demand
- Weak growth economics
Dogs in Boeing Company’s BCG mix are old, low-growth programs with little new sales upside: 747-8 ended in 2023 after 155 built, 757 ended in 2004 after 1,050 built, 737-700 is now a shrinking NG niche, and Starliner and SLS depend on limited NASA demand. In 2025/2026, they add more support cost than growth.
| Program | Signal |
|---|---|
| 747-8 | 155 built |
| 757 | 1,050 built |
| Starliner | 1 crewed test |
Question Marks
777X sits in the Question Mark box: it targets the premium long-haul widebody niche, where Boeing had 481 orders for the 777X family by year-end 2024, but no customer delivery yet. The program has demand, but years of delay and certification work mean it has not shown full market traction. Boeing still needs to turn that backlog into on-time, reliable deliveries before the jet can shift toward a Star position.
The T-7A Red Hawk is Boeing Company’s next-gen jet trainer, and the U.S. Air Force still plans to buy 351 aircraft under a program that aims to replace the T-38. But Boeing has not yet proven stable, large-scale production, so this stays a Question Mark in the BCG matrix. Its share will depend on execution, cost control, and whether follow-on orders beyond the first tranche materialize.
MQ-25 Stingray is in a growing unmanned carrier-tanker niche, and the U.S. Navy’s program of record calls for 76 aircraft. Boeing has moved into test flights, but the jet is still pre-rate production and has not yet become a meaningful revenue driver. It fits a Question Mark: high upside, low current share, and Boeing still has to prove scale before it can turn into a Star.
Wisk eVTOL, pre-revenue autonomy platform
Wisk is a pre-revenue autonomy platform, so it sits squarely in Boeing Company’s question marks. Urban air mobility has big upside, but adoption is still unproven, and Wisk has no commercial share to defend yet. In BCG terms, it is an invest-or-exit bet, not a cash cow.
- Pre-revenue, so no sales base
- High-growth market, uncertain demand
- Tech promise, no proven share
- Needs capital before scale
MQ-28 Ghost Bat, limited international scale
MQ-28 Ghost Bat is still a Question Mark: the autonomous combat-aircraft market is growing, but Boeing’s scale is narrow and mostly tied to Royal Australian Air Force testing. Boeing said the program passed 100 test flights in 2024, which shows real progress in uncrewed teaming, but not broad adoption. It needs far wider export and fleet orders to move out of Question Mark status.
- 100+ test flights, but limited deployment
- Strong uncrewed teaming potential
- Scale still depends on new orders
Boeing Company’s Question Marks are 777X, T-7A, MQ-25, Wisk, and MQ-28: each targets a growing niche, but none has yet built durable scale or cash flow. 777X had 481 orders by end-2024, T-7A is set for 351 Air Force jets, MQ-25 for 76 Navy aircraft, and MQ-28 has passed 100 test flights, yet all still need execution to win share.
| Program | Signal |
|---|---|
| 777X | 481 orders |
| T-7A | 351 planned |
| MQ-25 | 76 planned |
| MQ-28 | 100+ flights |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.
